Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C E Barry

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Trends in Microbiology|May 5, 2001
Interpreting cell wall 'virulence factors' of Mycobacterium tuberculosisC E Barry
Biochemical Pharmacology|January 7, 1998
New horizons in the treatment of tuberculosisC E Barry
The Canadian Journal of Infection Control : the Official Journal of the Community & Hospital Infection Control Association-Canada = Revue Canadienne De Prevention Des Infections|January 1, 1994
Where do all the placentas go?C E Barry
Current Opinion in Investigational Drugs (London, England : 2000)|January 31, 2002
Preclinical candidates and targets for tuberculosis therapyC E Barry
Trends in Microbiology|July 1, 1996
Drug sensitivity and environmental adaptation of mycobacterial cell wall componentsC E Barry, K Mdluli
Proceedings of the National Academy of Sciences of the United States of America|November 12, 1996
A common mechanism for the biosynthesis of methoxy and cyclopropyl mycolic acids in Mycobacterium tuberculosisY Yuan, C E Barry
Methods in Molecular Medicine|February 23, 2011
Analysis of the Lipids of Mycobacterium tuberculosisR A Slayden, C E Barry
Bioorganic Chemistry|July 5, 2001
The specificity of methyl transferases involved in trans mycolic acid biosynthesis in Mycobacterium tuberculosis and Mycobacterium smegmatisB G Schroeder, C E Barry
Nature Medicine|June 7, 2005
A low-carb diet for a high-octane pathogenH I Boshoff, C E Barry
Tuberculosis (Edinburgh, Scotland)|December 5, 2002
The role of KasA and KasB in the biosynthesis of meromycolic acids and isoniazid resistance in Mycobacterium tuberculosisR A Slayden, C E Barry
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Trends in Microbiology|May 5, 2001
Interpreting cell wall 'virulence factors' of Mycobacterium tuberculosisC E Barry
Biochemical Pharmacology|January 7, 1998
New horizons in the treatment of tuberculosisC E Barry
The Canadian Journal of Infection Control : the Official Journal of the Community & Hospital Infection Control Association-Canada = Revue Canadienne De Prevention Des Infections|January 1, 1994
Where do all the placentas go?C E Barry
Current Opinion in Investigational Drugs (London, England : 2000)|January 31, 2002
Preclinical candidates and targets for tuberculosis therapyC E Barry
Trends in Microbiology|July 1, 1996
Drug sensitivity and environmental adaptation of mycobacterial cell wall componentsC E Barry, K Mdluli
Proceedings of the National Academy of Sciences of the United States of America|November 12, 1996
A common mechanism for the biosynthesis of methoxy and cyclopropyl mycolic acids in Mycobacterium tuberculosisY Yuan, C E Barry
Methods in Molecular Medicine|February 23, 2011
Analysis of the Lipids of Mycobacterium tuberculosisR A Slayden, C E Barry
Bioorganic Chemistry|July 5, 2001
The specificity of methyl transferases involved in trans mycolic acid biosynthesis in Mycobacterium tuberculosis and Mycobacterium smegmatisB G Schroeder, C E Barry
Nature Medicine|June 7, 2005
A low-carb diet for a high-octane pathogenH I Boshoff, C E Barry
Tuberculosis (Edinburgh, Scotland)|December 5, 2002
The role of KasA and KasB in the biosynthesis of meromycolic acids and isoniazid resistance in Mycobacterium tuberculosisR A Slayden, C E Barry
Pageof 6